Back in May, Cytiva completed its integration with Pall Life Sciences, a move that CEO Emmanuel Ligner now describes as a “winning recipe” which has improved the company’s supply chain and fostered industry collaboration.
BetaLife wins top prize with its potential to provide regenerative medicines to patients with severe diabetes in Southeast Asia. Cytivas BioChallenge aims to support the innovation of biotec
As an industry leader and ecosystem builder, Cytiva has been supporting the Indian biotechnology industry for more than 30 years by forging close collaborations between the industry, government and academia. In a follow up to the comprehensive Cytiva Global Biopharma Resilience Index launched last year, this year’s study, which focuses on government policy and regulation and its impact on the resilience of the global biopharma system, reveals a bright spot in India. BioSpectrum India spoke to Benjamin James, HR Business Partner, Asia-Pacific, Cytiva to unearth what's happening in the Indian biopharma sector in terms of newer job opportunities. Edited excerpts-